THE ANTIMICROBIAL ACTIVITIES OF CYCLOSPORINE, FK506, AND RAPAMYCIN
TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1
PROSTAGLANDIN E PLUS FAMCICLOVIR—A NEW CONCEPT FOR THE TREATMENT OF SEVERE HEPATITIS B AFTER LIVER TRANSPLANTATION1,2
EVIDENCE THAT ACTIVATION OF HUMAN T CELLS BY PORCINE ENDOTHELIUM INVOLVES DIRECT RECOGNITION OF PORCINE SLA AND COSTIMULATION BY PORCINE LIGANDS FOR LFA-1 AND CD2
AN EVALUATION OF LEFLUNOMIDE IN THE CANINE RENAL TRANSPLANTATION MODEL1
UNRELATED LIVING KIDNEY DONORS
TRANSFORMING GROWTH FACTOR β1 IN RENAL ALLOGRAFT RECIPIENTS1
THE USEFULNESS OF 111IN-LABELED PLATELET SCINTIGRAPHY IN THE DIAGNOSIS OF PATIENTS WITH FEBRILE SYNDROME AND A NONFUNCTIONING RENAL GRAFT
PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG 37–325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST
PERCUTANEOUS RENAL ALLOGRAFT BIOPSY
FREQUENCY ANALYSIS OF DONOR-REACTIVE CYTOTOXIC T LYMPHOCYTE PRECURSORS IN LIVER ALLOGRAFT RECIPIENTS
DETECTION OF CYTOMEGALOVIRUS IN LIVER TRANSPLANT BIOPSIES
ORGANIZING PNEUMONIA FOLLOWING PULMONARY TRANSPLANTATION AND THE DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS1
MHC CLASS II AND ICAM-1 EXPRESSION AND LYMPHOCYTE SUBSETS IN TRANSBRONCHIAL BIOPSIES FROM LUNG TRANSPLANT RECIPIENTS1
CARDIAC ALLOGRAFT ATHEROSCLEROSIS IN THE RAT
PARTIAL INHIBITION OF ALLOGRAFT ARTERIOSCLEROSIS (CHRONIC REJECTION) BY 15-DEOXYSPERGUALIN1
THE EFFICACY OF NON-LACTATE-GENERATING METABOLITES AS SUBSTRATES FOR MAINTAINING DONOR TISSUES1
PREVENTION OF THE HUMORAL RESPONSE INDUCED BY AN ANTI-CD3 MONOCLONAL ANTIBODY BY DEOXYSPERGUALIN IN A MURINE MODEL1
TISSUE-SPECIFIC DIFFERENCES IN THE ESTABLISHMENT OF TOLERANCE
PREVENTION OF RECURRENT DIABETES IN SYNGENIC ISLET-TRANSPLANTED NOD MICE BY TRANSFUSION OF AUTOREACTIVE T LYMPHOCYTES1
HUMAN ISLET ISOLATION IN 104 CONSECUTIVE CASES
DRUG-INDUCED GINGIVAL OVERGROWTH AND CLASS II MAJOR HISTOCOMPATIBILITY ANTIGENS
THE EFFECT OF INTRAVENOUS IMMUNOGLOBULIN AND INTERFERON-ALPHA ON EPSTEIN-BARR VIRUS-INDUCED LYMPHOPROLIFERATIVE DISORDER IN A LIVER TRANSPLANT RECIPIENT1
THE DIRECT EFFECT OF FK506 AND RAPAMYCIN ON INTERLEUKIN 1(β) AND IMMUNOGLOBULIN PRODUCTION IN VITRO
THE SIGNIFICANCE OF LOCAL IMMUNOSUPPRESSION IN CANINE LIVER TRANSPLANTATION
PEDIATRIC INTRAVENOUS FK506—HOW MUCH ARE WE REALLY INFUSING?1
REJECTION AND HEPATITIS IN LIVER TRANSPLANTS
EBER-1 GENE EXPRESSION IN POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE
AUTHOR INDEX
SUBJECT INDEX